SR0136LRB103 31458 MST 59199 r SR0136 LRB103 31458 MST 59199 r
SR0136 LRB103 31458 MST 59199 r
1 SENATE RESOLUTION
2 WHEREAS, Respiratory Syncytial Virus disease (RSV) is a
3 highly transmissible, seasonal virus that can have severe and
4 unpredictable outcomes for infants, including hospitalization;
5 and
6 WHEREAS, Nearly all children will be infected with RSV by
7 age two, and most infants requiring hospitalization were
8 previously healthy and born at term; and
9 WHEREAS, RSV is the leading cause of hospitalization among
10 infants in the U.S.; and
11 WHEREAS, RSV is the most common cause of bronchiolitis
12 (inflammation of the small airways in the lung) and pneumonia
13 (infection of the lungs) in children younger than one year of
14 age in the U.S.; and
15 WHEREAS, The current RSV season has resulted in
16 significant morbidity and increased mortality; and
17 WHEREAS, In the U.S., RSV infections typically occur
18 during late fall, winter, and early spring, which means urgent
19 preparation is needed; and
SR0136 LRB103 31458 MST 59199 r
SR0136- 2 -LRB103 31458 MST 59199 r SR0136 - 2 - LRB103 31458 MST 59199 r
SR0136 - 2 - LRB103 31458 MST 59199 r
1 WHEREAS, Monoclonal antibodies show promise in
2 preventative protection against RSV; and
3 WHEREAS, RSV disproportionally affects infants with
4 Medicaid coverage, Native Americans, and Alaskan Natives; and
5 WHEREAS, The Vaccines For Children (VFC) program is a
6 federally-funded program that provides vaccines at no cost to
7 children who might not otherwise be vaccinated because of
8 inability to pay; and
9 WHEREAS, VFC coverage is critical to ensure equity and
10 access for all infants in order to have the greatest impact on
11 disease burden; therefore, be it
12 RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL
13 ASSEMBLY OF THE STATE OF ILLINOIS, that we urge the Centers for
14 Disease Control and Prevention to include new RSV immunization
15 technologies (including vaccines and monoclonal antibodies),
16 within the federal VFC program if the Advisory Committee on
17 Immunization Practices of the Centers for Disease Control and
18 Prevention issues administrative recommendations that are
19 subsequently approved by the Director of the Centers for
20 Disease Control and Prevention; and be it further
21 RESOLVED, That suitable copies of this resolution be
SR0136 - 2 - LRB103 31458 MST 59199 r
SR0136- 3 -LRB103 31458 MST 59199 r SR0136 - 3 - LRB103 31458 MST 59199 r
SR0136 - 3 - LRB103 31458 MST 59199 r
1 delivered to Director of the Centers for Disease Control and
2 Prevention Rochelle Walensky, Administrator of the Centers for
3 Medicare and Medicaid Services (CMS) Chiquita Brooks-LaSure,
4 and Secretary of the Department of Health and Human Services
5 Xavier Becerra.
SR0136 - 3 - LRB103 31458 MST 59199 r